Envestnet Portfolio Solutions
RPRX icon

Envestnet Portfolio Solutions’s Royalty Pharma RPRX Stock Holding History

Envestnet Portfolio Solutions’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-9,616
Closed -$254K – 1731
2024
Q2 		$254K Buy
+9,616
New +$267K ﹤0.01% 1470

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Envestnet Portfolio Solutions's RPRX Position: Q3 2024 in Review

Envestnet Portfolio Solutions sold out of Royalty Pharma (RPRX) in Q3 2024, closing a stake of 9,616 shares — an estimated $254K sold.

Envestnet Portfolio Solutions first reported a position in RPRX in Q2 2024 and held it in 1 quarter. The position peaked at $254K in Q2 2024. 395 funds tracked by Wall St. Rank hold RPRX as of Q3 2024.

  • Envestnet Portfolio Solutions reported no remaining Royalty Pharma position as of Q3 2024 after selling out during the quarter.
  • Envestnet Portfolio Solutions sold 9,616 Royalty Pharma shares in Q3 2024, an estimated $254K.
  • Envestnet Portfolio Solutions first reported a position in Royalty Pharma in Q2 2024 and held it in 1 quarter.
  • Envestnet Portfolio Solutions's Royalty Pharma position peaked at $254K in Q2 2024.
  • 395 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2024.

Based on Envestnet Portfolio Solutions's 13F filing for Q3 2024, filed 31 Oct 2024.